NEW YORK (GenomeWeb News) – Vermillion said today that it has obtained permits and completed regulatory processes required for opening a clinical reference laboratory.

In a filing with the US Securities and Exchange Commission, the company said that the lab, Aspira Labs, "will offer tests related to gynecologic oncology and women’s health," including its OVA1 ovarian cancer test.

The lab will be led by Herbert Fritsche, formerly clinical chemistry section chief in the Department of Pathology and Laboratory Medicine at MD Anderson Cancer Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

New Mexico is re-doing its proposed science education standards after criticism, the Associated Press reports.

Agbio executives say gene editing will speed up breeding efforts, according to the Wall Street Journal.

La Trobe University's Jenny Graves has won the $250,000 Prime Minister's Prize for Science, the Guardian reports.

In Cell this week: post-treatment changes to melanoma genome, multi-omics analysis of muscle-invasive bladder cancer, and more.